With half the children under five in India being malnourished, the present Covid-19 crisis could further impact child nutrition and service delivery across the country that is in the grip of a ferocious second wave, said the UN Children's Fund UNICEF.
"As vaccine supply continues to improve and vaccination capacity gets enhanced in all federating units, we continue to expand the categories of those who are eligible to get vaccinated," Umar said on Twitter.
Pakistan has lifted a rule barring the use of AstraZeneca's COVID-19 vaccine for people below 40 years old, in a bid to help inoculate people who need to travel for education or jobs abroad, particularly Saudi Arabia, a health official said.
Since the coronavirus first emerged in central China, Beijing has mostly managed to bring the country's outbreak under control, and has administered over 777 million vaccine doses after a sluggish start.
Government spokesman Tareq Al Mizrem said foreign travellers will need to have been fully inoculated with one of the four vaccines that the Gulf country has approved — Pfizer/BioNTech, AstraZeneca, Moderna and Johnson & Johnson.
With 88 more deaths and 4,000 new cases of COVID-19 infections all over Pakistan, inoculation of people aged 30 years and above started from Saturday as the National Assembly was informed that local production of the anti-coronavirus vaccine has begun.
The National Institute of Health (NIH) of Islamabad has begun the production of a single-dose Chinese coronavirus vaccine believing the initiative will help meet Pakistan's vaccine needs.
The UAE authorities said that the COVID-19 vaccines available in the country that have proven effective in reducing infection rates, though not preventing it completely and thus urged everyone to keep following the precautionary measures.
The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People's Vaccine Alliance (PVA), a coalition campaigning for wider access to COVID vaccines...
The jab, produced by Serum Institute of India under licence from the US-based Novavax, will now be distributed as part of global vaccine-sharing system Covax, "giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries", WHO said in a statement.